BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38537314)

  • 1. Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
    Geurts BS; Zeverijn LJ; van Berge Henegouwen JM; van der Wijngaart H; Hoes LR; de Wit GF; Spiekman IA; Battaglia TW; van Beek DM; Roepman P; Jansen AM; de Leng WW; Broeks A; Labots M; van Herpen CM; Gelderblom H; Verheul HM; Snaebjornsson P; Voest EE
    J Pathol; 2024 Jul; 263(3):288-299. PubMed ID: 38747304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability: A 2024 update.
    Yamamoto H; Watanabe Y; Arai H; Umemoto K; Tateishi K; Sunakawa Y
    Cancer Sci; 2024 Jun; 115(6):1738-1748. PubMed ID: 38528657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
    Ambrosini M; Rousseau B; Manca P; Artz O; Marabelle A; André T; Maddalena G; Mazzoli G; Intini R; Cohen R; Cercek A; Segal NH; Saltz L; Varghese AM; Yaeger R; Nusrat M; Goldberg Z; Ku GY; El Dika I; Margalit O; Grinshpun A; Kasi P; Schilsky R; Lutfi A; Shacham-Shmueli E; Khan Afghan M; Weiss L; Westphalen CB; Conca V; Decker B; Randon G; Elez E; Fakih M; Schrock AB; Cremolini C; Jayachandran P; Overman MJ; Lonardi S; Pietrantonio F
    Ann Oncol; 2024 May; ():. PubMed ID: 38777726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
    Fornaro L; Lonardi S; Catanese S; Nappo F; Pietrantonio F; Pellino A; Angerilli V; Signorini F; Salani F; Murgioni S; Neculaescu IA; Bruno R; Vivaldi C; Ricagno G; Masi G; Bergamo F; Ugolini C; Fassan M
    Gastric Cancer; 2023 Nov; 26(6):958-968. PubMed ID: 37382783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art: Targeting microsatellite instability in gastrointestinal cancers.
    Mencel J; Alves A; Angelis V; Gerlinger M; Starling N
    Crit Rev Oncol Hematol; 2024 Jul; 199():104387. PubMed ID: 38734279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-operative management after immune checkpoint inhibitors for early-stage, dMMR/MSI-H gastrointestinal cancers.
    Fazio R; Audisio A; Daprà V; Conti C; Benhima N; Abbassi FZ; Assaf I; Hendlisz A; Sclafani F
    Cancer Treat Rev; 2024 Jul; 128():102752. PubMed ID: 38772170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
    Gervaso L; Ciardiello D; Oliveira RA; Borghesani M; Guidi L; Benini L; Algeri L; Spada F; Zampino MG; Cella CA; Fazio N
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organ preservation in locally advanced colorectal cancer with microsatellite instability-high after immunotherapy].
    Hong ZG; Xiao BY; Ding PR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):353-358. PubMed ID: 38644240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
    Guven DC; Kavgaci G; Erul E; Syed MP; Magge T; Saeed A; Yalcin S; Sahin IH
    Oncologist; 2024 May; 29(5):e580-e600. PubMed ID: 38309719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial.
    Wu Z; Zhang Y; Cheng Y; Li J; Li F; Wang C; Shi L; Qin G; Zhan W; Cai Y; Xie X; Ling J; Hu H; Zhang J; Deng Y
    Med; 2024 May; ():. PubMed ID: 38795703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway.
    Luvero D; Cundari GB; Ficarola F; Plotti F; Terranova C; Montera R; Bogani G; Silvagni A; Celoro F; Angioli R
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer.
    Pacholczak-Madej R; Bartoletti M; Musacchio L; Püsküllüoglu M; Blecharz P; Lorusso D
    Expert Rev Anticancer Ther; 2024 Jun; ():1-13. PubMed ID: 38863432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
    Sia TY; Wan V; Finlan M; Zhou QC; Iasonos A; Zivanovic O; Sonoda Y; Chi DS; Long Roche K; Jewell E; Tew WP; O'Cearbhaill RE; Cohen S; Makker V; Liu YL; Friedman CF; Kyi C; Zamarin D; Gardner G
    Int J Gynecol Cancer; 2024 Apr; 34(4):594-601. PubMed ID: 38296517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?
    Cercek A
    N Engl J Med; 2024 Jun; 390(21):2024-2025. PubMed ID: 38838316
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition.
    Marinelli D; Sabatini A; Bengala E; Ciurluini F; Picone V; Santini D; Pietrantonio F; Rossini D; Cremolini C
    ESMO Open; 2024 Jun; 9(6):103483. PubMed ID: 38833965
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.
    Moreau M; Alouani E; Flecchia C; Falcoz A; Gallois C; Auclin E; André T; Cohen R; Hollebecque A; Turpin A; Pernot S; Masson T; Di Fiore F; Dutherge M; Mazard T; Hautefeuille V; Van Laethem JL; De la Fouchardière C; Perkins G; Ben-Abdelghani M; Sclafani F; Aparicio T; Kim S; Vernerey D; Taieb J; Guimbaud R; Tougeron D
    Eur J Cancer; 2024 May; 202():114033. PubMed ID: 38537314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
    Quintanilha JCF; Graf RP; Fisher VA; Oxnard GR; Ellis H; Panarelli N; Lin DI; Li G; Huang RSP; Ross JS; Myer PA; Klempner SJ
    JAMA Netw Open; 2023 Jan; 6(1):e2252244. PubMed ID: 36689222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study.
    Tougeron D; Sueur B; Zaanan A; de la Fouchardiére C; Sefrioui D; Lecomte T; Aparicio T; Des Guetz G; Artru P; Hautefeuille V; Coriat R; Moulin V; Locher C; Touchefeu Y; Lecaille C; Goujon G; Ferru A; Evrard C; Chautard R; Gentilhomme L; Vernerey D; Taieb J; André T; Henriques J; Cohen R;
    Int J Cancer; 2020 Jul; 147(1):285-296. PubMed ID: 31970760
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.